Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: May 10, 2011

Premium

HTG Molecular Diagnostics has appointed John Lubniewski to be its chief business officer. He will be responsible for sales, marketing, and product development teams in the areas of molecular testing, translational medicine, and pharmaceutical clinical development and pathology laboratory diagnostics, according to the Tucson, Ariz.-based firm.

Lubniewski formerly was involved in senior management at Ventana Medical Systems, and he was a business development manager at Corning.


Ram Laxman has been hired as the vice president of sales and sales operations in Asia at Pacific Biosciences. He joins PacBio after seven years at Illumina, most recently managing its Asian distributor organization across Australia, Taiwan, Korea, Thailand, Malaysia, Philippines, Indonesia, Vietnam, India, and Pakistan.

Previously, he was an application scientist at Illumina and Research Instruments. Laxman holds a PhD in molecular biology from the National University of Singapore's School of Medicine.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.